These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 11438502

  • 1. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis.
    Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG.
    Gastroenterology; 2001 Jul; 121(1):131-9. PubMed ID: 11438502
    [Abstract] [Full Text] [Related]

  • 2. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
    Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P.
    Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
    [Abstract] [Full Text] [Related]

  • 3. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN.
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [Abstract] [Full Text] [Related]

  • 4. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia.
    Meijers JC, Oudijk EJ, Mosnier LO, Bos R, Bouma BN, Nieuwenhuis HK, Fijnheer R.
    Br J Haematol; 2000 Mar; 108(3):518-23. PubMed ID: 10759708
    [Abstract] [Full Text] [Related]

  • 5. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y, Honda Y.
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [Abstract] [Full Text] [Related]

  • 6. Thrombin activatable fibrinolysis inhibitor (TAFI) at the interface between coagulation and fibrinolysis.
    Bouma BN, Mosnier LO.
    Pathophysiol Haemost Thromb; 2019 Jul; 33(5-6):375-81. PubMed ID: 15692247
    [Abstract] [Full Text] [Related]

  • 7. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
    Watanabe R, Wada H, Watanabe Y, Sakakura M, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Nobori T, Shiku H.
    Thromb Res; 2001 Oct 01; 104(1):1-6. PubMed ID: 11583733
    [Abstract] [Full Text] [Related]

  • 8. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
    Von dem Borne PA, Bajzar L, Meijers JC, Nesheim ME, Bouma BN.
    J Clin Invest; 1997 May 15; 99(10):2323-7. PubMed ID: 9153272
    [Abstract] [Full Text] [Related]

  • 9. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.
    Hryszko T, Malyszko J, Malyszko JS, Brzosko S, Pawlak K, Mysliwiec M.
    Nephrol Dial Transplant; 2001 Aug 15; 16(8):1692-6. PubMed ID: 11477176
    [Abstract] [Full Text] [Related]

  • 10. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP, Blombäck M.
    Thromb Res; 2002 Apr 01; 106(1):59-62. PubMed ID: 12165290
    [Abstract] [Full Text] [Related]

  • 11. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.
    Bajzar L, Manuel R, Nesheim ME.
    J Biol Chem; 1995 Jun 16; 270(24):14477-84. PubMed ID: 7782309
    [Abstract] [Full Text] [Related]

  • 12. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 16; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 13. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
    Mosnier LO, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Jan 16; 85(1):5-11. PubMed ID: 11204587
    [Abstract] [Full Text] [Related]

  • 14. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).
    Bouma BN, Marx PF, Mosnier LO, Meijers JC.
    Thromb Res; 2001 Mar 01; 101(5):329-54. PubMed ID: 11297751
    [Abstract] [Full Text] [Related]

  • 15. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P, Heylen E, Willemse J, Djordjević V, Radojković D, Colović M, Elezović I, Hendriks D.
    Srp Arh Celok Lek; 2010 Jan 01; 138 Suppl 1():74-8. PubMed ID: 20229688
    [Abstract] [Full Text] [Related]

  • 16. Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis.
    Gitto S, Romanelli RG, Cellai AP, Lami D, Vizzutti F, Abbate R, Margheri F, Fibbi G, Del Rosso M, Laffi G.
    Intern Emerg Med; 2021 Mar 01; 16(2):339-347. PubMed ID: 32445164
    [Abstract] [Full Text] [Related]

  • 17. A new functional assay of thrombin activatable fibrinolysis inhibitor.
    Guimarães AH, Bertina RM, Rijken DC.
    J Thromb Haemost; 2005 Jun 01; 3(6):1284-92. PubMed ID: 15946219
    [Abstract] [Full Text] [Related]

  • 18. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N, Guldiken S, Demir M, Tugrul A.
    Clin Appl Thromb Hemost; 2010 Oct 01; 16(5):568-73. PubMed ID: 19959491
    [Abstract] [Full Text] [Related]

  • 19. Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor.
    Ammollo CT, Semeraro F, Incampo F, Semeraro N, Colucci M.
    J Thromb Haemost; 2010 Apr 01; 8(4):790-8. PubMed ID: 20088944
    [Abstract] [Full Text] [Related]

  • 20. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
    Nielsen VG, Ellis TC.
    Blood Coagul Fibrinolysis; 2007 Jan 01; 18(1):29-33. PubMed ID: 17179823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.